Sample Collection for Cerebrovascular Disorders
Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
Recruiting
Observational Study
Cerebrovascular Diseases
Ischemic Stroke
Repository
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 900 (estimated)
- Sponsor
- Cedars-Sinai Medical Center · Other
Who this trial is looking for
This trial is looking for patients with cerebrovascular diseases like ischemic stroke. Participants will provide samples such as blood and tissue to help research future treatments and understand these conditions better.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with cerebrovascular disease.
- I can provide clinical follow-up data.
- I am willing to give written consent to participate.
You may not be able to join if
- I am pregnant.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
This study encompasses the maintenance and utilization of a repository of samples from patients with cerebrovascular disease and stroke. The types of tissue taken are blood, cerebrospinal fluid (CSF), tissue, and microdialysis samples. Future analysis of these samples can potentially help investigators to better categorize groups of patients, understand the underlying etiology of these pathologies…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All patients diagnosed with cerebral vascular disease, regardless of gender, age, ethnicity/race, stage of disease or treatment, are eligible.
* Expected availability of clinical follow up data
* Participants must be willing to provide written, informed consent obtained in acc…
Contacts